Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)
R&D Expense Growth
-2.70%
Quarterly · Period ending:
BIO R&D Expense Growth
Latest reported-2.70%period ending
Latest reported-2.70%period ending
BIO Quarterly R&D Growth (QoQ) (0.00% → -2.70%)
Latest values, visible window
High-resolution chart · PNG
BIO r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -2.7027% | |
| -4.2618% | |
| -7.8541% | |
| 17.8512% | |
| -17.6871% | |
| -7.6911% | |
| -12.4982% | |
| 53.4416% | |
| -7.3013% | |
| 2.8322% | |
| 42.9034% | |
| -33.0663% | |
| -13.2206% | |
| 13.219% | |
| -5.3596% | |
| 4.3485% | |
| 12.596% | |
| -14.7954% | |
| 8.3622% | |
| 1.7195% | |
| -14.2345% | |
| 12.388% | |
| 10.444% | |
| 14.5468% | |
| 5.4378% | |
| -13.6081% | |
| 19.0326% | |
| -4.3454% | |
| 5.3537% | |
| -10.361% | |
| 7.7754% | |
| 3.7829% | |
| -3.9998% | |
| -35.657% | |
| 25.1678% | |
| -1.9977% | |
| 26.5418% | |
| -13.9982% | |
| 15.2612% | |
| -4.307% | |
| 7.3787% | |
| -13.0639% | |
| 28.9621% | |
| -6.8984% | |
| -1.3877% | |
| -20.3839% | |
| 12.3158% | |
| -5.2605% | |
| 6.0408% | |
| -5.9178% | |
| 5.5329% | |
| -0.5712% | |
| 2.4701% | |
| -13.1087% | |
| 21.9839% | |
| -6.3666% | |
| -1.1092% | |
| 5.6094% | |
| 10.4105% | |
| -5.8556% | |
| 12.8247% | |
| -5.6045% | |
| 5.5815% | |
| -2.2525% | |
| 8.9387% | |
| -9.5417% | |
| 12.6379% | |
| -6.8173% | |
| 14.1446% | |
| -9.6498% | |
| 5.8975% | |
| -7.7212% | |
| 12.2436% | |
| -5.9365% | |
| 20.2444% | |
| -4.6297% | |
| 6.0187% | |
| -1.6354% | |
| 7.5449% | |
| 0.0549% | |
| 10.2524% | |
| -9.7014% | |
| 8.4958% | |
| 0.6105% | |
| 6.2484% | |
| -15.8758% | |
| 19.9541% | |
| 4.0556% | |
| -2.2164% | |
| -0.9592% | |
| 10.9489% | |
| 4.5884% | |
| 6.2792% | |
| -6.6026% | |
| 14.5687% | |
| 0.9189% | |
| -2.1491% | |
| -7.9494% | |
| 19.3433% | |
| 4.0902% |